Sickle Cell Care in Africa Needs to Go Beyond Survival

African health systems need to strengthen early diagnosis and expand access to effective treatments for sickle cell disease, according to experts.

Current Challenges

Sickle cell disease is an inherited blood disorder that can cause severe episodes of pain, anaemia, and other life-threatening complications. While advances in medical research have expanded treatment options, high costs, limited screening, and gaps in healthcare delivery continue to restrict access across Africa.

• Hydroxyurea, a disease-modifying medicine, can reduce painful episodes and improve patients' quality of life, but its availability and affordability vary across countries.
• Other treatments, such as crizanlizumab and L-glutamine, are also available, but their accessibility is limited due to high costs and infrastructure requirements.

Experts emphasize the need for African governments to invest in healthcare systems, strengthen research partnerships, and promote public education to improve sickle cell outcomes.

Source: KBC Digital. AI-assisted summary.